Bone marrow-derived mesenchymal stem cells reduce CCl4-induced kidney injury and fibrosis in male Wistar rats

Asmaa Adel Manal Abdul-Hamid Samraa H. Abdel-Kawi Mohamed A. Abdelaziz Hader I. Sakr Osama M. Ahmed a Histology,Cell Biology and Genetic Division,Zoology Department,Faculty of Science,Beni-Suef University,Beni-Suef,Egyptb Medical Histology and Cell Biology Department,Faculty of Medicine,Beni-Suef University,Beni-Suef,Egyptc Basic Medical Sciences Department,College of Medicine,Prince Sattam Bin Abdulaziz University,Al-Kharj,Kingdom of Saudi Arabiad Medical Physiology Department,Faculty of Medicine,Al-Azhar University,Cairo,Egypte Department of Medical Physiology,Faculty of Medicine,Cairo University,Cairo,Egyptf Department of Medical Physiology,General Medicine Practice Program,Batterjee Medical College,Jeddah,Saudi Arabiag Molecular Physiology Division,Zoology Department,Faculty of Science,Beni-Suef University,Beni-Suef,Egypt

DOI: https://doi.org/10.1080/0886022x.2024.2319330

IF: 3.222

2024-07-26

Renal Failure

Abstract:Aim This study explores the possible therapeutic role of rats and mice bone marrow-derived mesenchymal stem cells (BM-MSCs) on renal damage and toxicity brought on by carbon tetrachloride (CCl 4 ) in Wistar rats.

urology & nephrology